| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/02/2009 | US20090088339 Identification of activated receptors and ion channels |
| 04/02/2009 | US20090087910 PRIMER-EXTENSION BASED METHOD FOR THE GENERATION OF siRNA/miRNA EXPRESSION VECTORS |
| 04/02/2009 | US20090087907 Compositions and Methods for Growth of Pluripotent Cells |
| 04/02/2009 | US20090087906 Novel cell-based assays for g-protein-coupled receptor-mediated activities |
| 04/02/2009 | US20090087905 VEGF-D polynucleotides and methods of use |
| 04/02/2009 | US20090087893 Modified Expandase Enzyme and its use |
| 04/02/2009 | US20090087892 Methods for producing mutant microbes useful for precious metal and bioenergy production |
| 04/02/2009 | US20090087883 Novel expression vector with enhanced gene expression capacity and method for using the same |
| 04/02/2009 | US20090087881 Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same |
| 04/02/2009 | US20090087879 Method for the production of a lysate used for cell-free protein biosynthesis |
| 04/02/2009 | US20090087878 polypeptide useful for production of plant growth regulators; herbicides and heat tolerance |
| 04/02/2009 | US20090087876 Methods and compositions useful for modulating drug-induced impairment |
| 04/02/2009 | US20090087874 Glucose dehydrogenase and production thereof |
| 04/02/2009 | US20090087863 Method For Detecting Polypeptide Toxic to Diabrotica Insects |
| 04/02/2009 | US20090087861 Chimeric Tymovirus-like Particles and Process Thereof |
| 04/02/2009 | US20090087853 Herbicide tolerant cotton plants and methods for producing and identifying same |
| 04/02/2009 | US20090087843 Molecular markers |
| 04/02/2009 | US20090087842 used to find a novel protein linked to the cytomatrix and considered to play an important role in synaptogenesis; detection and quantification of CAST |
| 04/02/2009 | US20090087836 Cytokines; fab fragments; fv fragments; monoclonal antibodies |
| 04/02/2009 | US20090087515 Gene encoding acetolactate synthase and use thereof |
| 04/02/2009 | US20090087481 Using mixture comprising colony stimulating factor, interleukin-5 and/or a mimetic as therapeutic tool in treatment of nervous system disorders |
| 04/02/2009 | US20090087478 Orally Deliverable and Anti-Toxin Antibodies and Methods for Making and Using Them |
| 04/02/2009 | US20090087474 Therapeutic use of growth factors,nsg29 and nsg31 |
| 04/02/2009 | US20090087458 Activatable recombinant neurotoxins |
| 04/02/2009 | US20090087449 Novel Peptide Compositions and the Use Thereof, in Particular, in the Preparation of Active Pharmaceutical Compositions Against the Hepatitis C Virus |
| 04/02/2009 | US20090087448 Stable Immunoprophylactic and Therapeutic Compositions Derived From Transgenic Plant Cells and Methods for Production |
| 04/02/2009 | US20090087446 Combination motif immune stimulatory oligonucleotides with improved activity |
| 04/02/2009 | US20090087445 Method for the Redox Potential-Dependent Detection of Target Molecules by Interacting Polypeptides |
| 04/02/2009 | US20090087439 Compositions and methods for diagnosing or treating psoriasis |
| 04/02/2009 | US20090087436 Compositions and methods for treating diseases |
| 04/02/2009 | US20090087435 Isolated Chimeric Proteins Of Modified Lumazine Synthase |
| 04/02/2009 | US20090087434 Nfia in glial fate determination, glioma therapy and astrocytoma treatment |
| 04/02/2009 | US20090087431 Methods of treating bone disorders with modulators of axl |
| 04/02/2009 | US20090087429 IL-17 homologous polypeptides and therapeutic uses thereof |
| 04/02/2009 | US20090087424 Modulating Retinal Pigmented Epithelium Permeaion By Inhibiting Or Activating VEGFR-1 |
| 04/02/2009 | US20090087423 Novel protein complex and use thereof |
| 04/02/2009 | US20090087421 Novel Recombinant Staphylokinase Derivatives and the Preparations and Applications thereof |
| 04/02/2009 | US20090087417 Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands |
| 04/02/2009 | US20090087416 novel B7-H3 and B7-H4 polypeptides useful for co-stimulating T cells, vectors containing the nucleic acid molecules, and cells containing the vectors |
| 04/02/2009 | US20090087412 Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression |
| 04/02/2009 | US20090087411 Long-acting interferons and derivatives thereof and methods thereof |
| 04/02/2009 | DE10362172B4 Wasch-und Reinigungsmittel mit Alpha-Amylase-Varianten mit verbesserter Alkaliaktivität Washing and cleaning agents with alpha-amylase variants with improved alkali activity |
| 04/02/2009 | CA2715078A1 Synthetic 5'utrs, expression vectors, and methods for increasing transgene expression |
| 04/02/2009 | CA2704153A1 Vaccine for rsv and mpv |
| 04/02/2009 | CA2701668A1 Factor involved in latent infection with herpesvirus, and use thereof |
| 04/02/2009 | CA2700986A1 Anti-glypican-3 antibody having improved kinetics in plasma |
| 04/02/2009 | CA2700981A1 Plants having increased biomass |
| 04/02/2009 | CA2700941A1 3.4 kb mitochondrial dna deletion for use in the detection of cancer |
| 04/02/2009 | CA2700926A1 Methods for modulating the proliferation and differentiation potential of stem cells and progenitor cells |
| 04/02/2009 | CA2700842A1 High concentration chitosan-nucleic acid polyplex compositions |
| 04/02/2009 | CA2700815A1 Optimized nucleic acid sequences for the expression of vb4-845 |
| 04/02/2009 | CA2700808A1 Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo |
| 04/02/2009 | CA2700701A1 Method of modifying isoelectric point of antibody via amino acid substitution in cdr |
| 04/02/2009 | CA2700635A1 Advanced cervical cell screening methods |
| 04/02/2009 | CA2700498A1 Anti-il-6 receptor antibody |
| 04/02/2009 | CA2700441A1 C5a binding nucleic acids |
| 04/02/2009 | CA2700394A1 Modified antibody constant region |
| 04/02/2009 | CA2700391A1 Designed armadillo repeat proteins |
| 04/02/2009 | CA2700211A1 Production of isoprenoids |
| 04/02/2009 | CA2700170A1 Genomic editing in zebrafish using zinc finger nucleases |
| 04/02/2009 | CA2700162A1 Cell-permeabilising peptides and polypeptides for microbial cells |
| 04/02/2009 | CA2699769A1 Engineered zinc finger proteins targeting 5-enolpyruvyl shikimate-3-phosphate synthase genes |
| 04/02/2009 | CA2698609A1 Novel antibodies |
| 04/02/2009 | CA2687559A1 Enzymes involved in triterpene synthesis |
| 04/01/2009 | EP2042869A2 High affinity TCR proteins and methods |
| 04/01/2009 | EP2042606A1 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic use |
| 04/01/2009 | EP2042605A1 Integration optimised viral vectors for gene therapy |
| 04/01/2009 | EP2042604A1 VV promoter driven overexpression of recombinant antigens |
| 04/01/2009 | EP2042603A1 Phosphonate metabolizing plants |
| 04/01/2009 | EP2042602A1 Cosmid vector for plant transformation and use thereof |
| 04/01/2009 | EP2042601A1 Novel variant EGIII-like cellulase compositions |
| 04/01/2009 | EP2042600A1 A public and immunogenic CD4+ T Cell epitope of the hiv tat protein and its applications |
| 04/01/2009 | EP2042599A1 Method of making microencapsulated DNA for vaccination and gene therapy |
| 04/01/2009 | EP2042598A1 5T4 tumour-associated antigen for use in tumour immunotherapy |
| 04/01/2009 | EP2042597A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 04/01/2009 | EP2042596A1 Polypeptides involved in immune response |
| 04/01/2009 | EP2042595A1 Permanent inactivation of nucleases |
| 04/01/2009 | EP2042594A1 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| 04/01/2009 | EP2042591A1 Erythropoietin-producing organoid precursor, method of constructing the same and method of treating erythropoietin-related disease |
| 04/01/2009 | EP2042518A2 Dual specificity antibodies and methods of making and using |
| 04/01/2009 | EP2042512A2 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof |
| 04/01/2009 | EP2042510A2 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleid acid (siNA) |
| 04/01/2009 | EP2042509A1 Modulators of the function of FAS receptors and other proteins |
| 04/01/2009 | EP2042196A2 Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF) |
| 04/01/2009 | EP2041295A2 Methods for arbitrary peptide synthesis |
| 04/01/2009 | EP2041291A1 Inhibition of the liver tropism of adenoviral vectors |
| 04/01/2009 | EP2041290A2 Method of producing a multichimeric mouse and applications to study the immunopathogenesis of human tissue-specific pathologies |
| 04/01/2009 | EP2041289A2 Resistance to powdery mildew and absence of necrosis in cucumis sativus |
| 04/01/2009 | EP2041288A2 Rk2-based broad-host-range cloning vector useful for transfer of metagenomic libraries to a variety of bacterial species |
| 04/01/2009 | EP2041286A2 Process for making oligopeptides |
| 04/01/2009 | EP2041285A2 Nucleic acid molecules |
| 04/01/2009 | EP2041284A2 Production of stilbenes and derivatives in plant hairy root cultures |
| 04/01/2009 | EP2041282A2 Sdf-i binding nucleic acids |
| 04/01/2009 | EP2041281A2 Method for insulating in parallel double and single-stranded nucleic acids and for selectively removing double-stranded nucleic acids from a mixture of double and single-stranded nucleic acids |
| 04/01/2009 | EP2041280A1 Methods for enhancing a secretion efficiency of recombinant foreign protein in yeast expression system |
| 04/01/2009 | EP2041177A2 High affinity antibodies to human il-6 receptor |
| 04/01/2009 | EP2041171A2 Epitope-tag for surface-expressed proteins and uses thereof |
| 04/01/2009 | EP2041047A2 Fatty acid blends and uses therefor |
| 04/01/2009 | EP2040744A2 Live vaccine strains of francisella |
| 04/01/2009 | EP2040538A2 Immunodeficient mice transgenic for hla class i and hla class ii molecules and their uses |